甲状腺乳头状癌胸锁乳突肌-胸骨舌骨肌间淋巴结转移风险分析
回顾性分析85例颈侧cN1甲状腺乳头状癌患者,54例(63.5%)标本见淋巴组织,20例(23.5%)病理阳性。多因素分析示LNSS转移与原发肿瘤大小(OR=1.819)及Ⅳ区淋巴结转移(OR=2.190)相关。
要点
- 颈侧cN1 PTC患者LNSS病理阳性率为23.5%。
- 原发肿瘤大小与LNSS转移相关(OR=1.819,95%CI 1.050-3.850,P=0.002)。
- Ⅳ区淋巴结转移与LNSS转移相关(OR=2.190,95%CI 1.132-2.334,P=0.005)。
核心结论
- PTC患者LNSS淋巴结转移隐匿但并非少见,Ⅳ区淋巴结转移明显者LNSS转移风险更高。
研究设计与样本
- 回顾性分析2013年5月1日至2016年5月31日复旦大学附属肿瘤医院头颈外科行手术治疗且有LNSS分区的颈侧cN1 PTC患者85例,采用Logistic回归分析。
主要发现
- 85例患者中54例(63.5%)手术标本见LNSS淋巴组织,20例(23.5%)病理确诊LNSS转移阳性。
- 清扫见淋巴组织组术前血清TSH水平、TPO-Ab水平明显高于纤维脂肪组织组(P<0.05),患侧多病灶比例高(P<0.05)。
- 多因素分析示LNSS转移与原发肿瘤大小(OR=1.819,95%CI 1.050-3.850,P=0.002)及Ⅳ区淋巴结转移(OR=2.190,95%CI 1.132-2.334,P=0.005)相关。
- LNSS阳性数目与Ⅳ区淋巴结阳性数目密切相关(P<0.05)。
关键数值与推荐
- LNSS转移与原发肿瘤大小相关:OR=1.819(95%CI 1.050-3.850,P=0.002)。
- LNSS转移与Ⅳ区淋巴结转移相关:OR=2.190(95%CI 1.132-2.334,P=0.005)。
- 淋巴组织组术前TSH、TPO-Ab水平及患侧多病灶比例高于纤维脂肪组织组(P<0.05)。
- LNSS阳性数目与Ⅳ区阳性数目密切相关(P<0.05)。
临床怎么用
- 对颈侧cN1 PTC患者,尤其Ⅳ区淋巴结转移明显者,应注意LNSS转移风险以保证手术彻底性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the risk factors for metastasis of lymph nodes between sternocleidomastoid and sternohyoid muscle (LNSS) in papillary thyroid cancer (PTC). Methods: Papillary thyroid cancer patients with clinically positive lateral lymph node metastasis (cN1) who underwent surgery including LNSS dissection between May 1, 2013 and May 31, 2016 at the Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center were retrospectively studied. Logistic regression analysis was performed to evaluate possible clinicopathological factors related to LNSS metastasis. Results: In 85 patients, 54 patients (63.5%) showed LNSS in their surgical specimen, and 20 patients (23.5%) had pathologically positive LNSS metastasis. Patients with LNSS showed preoperatively higher levels of serum thyroid stimulating hormone (TSH) and thyroid peroxidase antibody (TPO-Ab) compared to patients only with fibrofatty tissues between sternocleidomastoid and sternohyoid muscle (P<0.05), and they also displayed a higher proportion of multifocality in ipsilateral thyroid lobe (P<0.05). Multi-factor analysis indicated that LNSS metastasis was correlated with original tumor size (OR=1.819, 95%CI 1.050-3.850, P=0.002) and Level Ⅳ lymph node metastasis (OR=2.190, 95%CI 1.132-2.334, P=0.005). Furthermore, the number of positive LNSS was tightly correlated to that of level Ⅳ lymph node metastasis(P<0.05). Conclusion: LNSS metastasis is occult but not quite rare in PTC. Patients with extensive lymph node metastasis in Level Ⅳhave a higher risk for metastasis of LNSS. 目的: 分析甲状腺乳头状癌(papillary thyroid cancer, PTC)中胸锁乳突肌-胸骨舌骨肌间(lymph node between sternocleidomastoid and sternohyoid muscle,LNSS)淋巴结转移的危险因素。 方法: 回顾性分析复旦大学附属肿瘤医院头颈外科2013年5月1日至2016年5月31日行手术治疗且有LNSS分区的颈侧cN1 PTC患者,采用Logistic回归分析与LNSS相关的临床病理学因素。 结果: 85例患者中LNSS存淋巴组织者54(63.5%)例,病理确诊阳性20(23.5%)例。清扫见淋巴组织组患者术前血清促甲状腺激素(thyroid stimulating hormone,TSH)水平、甲状腺过氧化物酶抗体(thyroid peroxidase antibody, TPO-Ab)水平明显高于纤维脂肪组织组(P<0.05),同时患侧多病灶比例高(P<0.05)。多因素分析提示54例患者中LNSS转移与原发肿瘤大小(OR=1.819,95%CI 1.050~3.850,P=0.002)及Ⅳ区淋巴结转移(OR=2.190,95%CI 1.132~2.334,P=0.005)相关,且LNSS阳性数目与Ⅳ区阳性数目密切相关(P<0.05)。 结论: PTC患者LNSS淋巴结转移隐匿但并非少见,对于颈侧Ⅳ区淋巴结转移明显者更应注意LNSS转移的风险以保证手术彻底性。.
引用
- Sun GH, Qu N, Hu JQ, et al. [Risk for metastasis of lymph node between sternocleidomastoid and sternohyoid muscle in papillary thyroid cancer]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017. PMID: 28441800. doi:10.3760/cma.j.issn.1673-0860.2017.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。